AI assistant
Sending…
RESMED INC — Director's Dealing 2015
Nov 23, 2015
30071_dirs_2015-11-23_edf9b252-95ac-4c92-996a-e438bf076d01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-11-19
Reporting Person: FARRELL PETER C (Director, Chairman of the Board)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-19 | ResMed Common Stock Options | $58.24 | A | 20492 | Acquired | 2022-11-19 | ResMed Common Stock (20492) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 417314 | Direct |
| ResMed Common Stock | 87776 | Indirect |
| ResMed Common Stock | 52204 | Indirect |
Footnotes
F1: Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholder's meeting following grant date.
F2: Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29